Abstract B051: A T-cell signature in circulating cell-free DNA at time of diagnosis predicts response to checkpoint inhibition
Clinical Cancer Research2024Vol. 30(21_Supplement), pp. B051–B051
Phil F. Xie, Zohar Etzioni, Chun‐Xiao Song, Richard Owen, Mark R. Middleton, Xin Lü, Benjamin Schuster‐Böckler
Abstract
Abstract This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR017) of the Conference Program/Proceedings. Citation Format: Phil Xie, Zohar Etzioni, Chun-Xiao Song, Richard P Owen, Mark R Middleton, Xin Lu, Benjamin Schuster-Boeckler. A T-cell signature in circulating cell-free DNA at time of diagnosis predicts response to checkpoint inhibition [abstract]. In: Proceedings of the AACR Special Conference: Liquid Biopsy: From Discovery to Clinical Implementation; 2024 Nov 13-16; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(21_Suppl):Abstract nr B051.
Related Papers
- → A new methodology to preserve the original proportion and integrity of cell‐free fetal DNA in maternal plasma during sample processing and storage(2010)100 cited
- → Quantitative mechanisms of DNA damage sensing and signaling(2019)15 cited
- → Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid(2005)13 cited
- → Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma(2015)5 cited
- → Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cel – free fetal DNA(2013)2 cited